FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048572815> ?p ?o ?g. }

• W3048572815 endingPage "1066" @default.
• W3048572815 startingPage "1066" @default.
• W3048572815 abstract "<h3>Importance</h3> Topical calcineurin inhibitors (TCIs), primarily used to treat atopic dermatitis (AD), carry a black box label warning users about the potential for increased skin cancer risk. The risk associated with keratinocyte carcinoma (KC), the most common cancer, defined as basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), remains poorly defined because findings from large-scale postmarketing surveillance studies have not been reported. <h3>Objectives</h3> To examine KC risk overall and by subtype (BCC and SCC) among adults with AD exposed to TCIs compared with those exposed to topical corticosteroids (primary comparator group) and those unexposed to TCIs or topical corticosteroids (alternative comparator group) as well as alterations in risk with TCI dose, frequency, and duration of exposure. <h3>Design, Setting, and Participants</h3> A retrospective cohort study was conducted at Kaiser Permanente Northern California, a large, integrated health care delivery system, of adults 40 years or older (n = 93 746) with a physician-rendered diagnosis of AD or dermatitis. Patients who were diagnosed from January 1, 2002, to December 31, 2013, were included, with follow-up through December 31, 2017. Data analysis was conducted from June 1, 2016, to October 1, 2018. <h3>Exposures</h3> Time-varying pharmacy-dispensed TCI exposure (n = 7033) over the study period was compared with topical corticosteroids (n = 73 674) and no TCI or topical corticosteroid exposure (n = 46 141). <h3>Main Outcomes and Measures</h3> Electronic pathologic testing–validated incident KCs (n = 7744). <h3>Results</h3> Among a cohort of 93 746 members, the mean (SD) age was 58.5 (12.7) years, and 55 023 patients (58.7%) were women. Multivariable Cox proportional hazards regression revealed no association between TCI exposure and KC risk (adjusted hazard ratio [aHR], 1.02; 95% CI, 0.93-1.13) compared with topical corticosteroid exposure. Similarly, there were no significant differences in BCC risk (aHR, 1.01; 95% CI, 0.90-1.14, TCI vs topical corticosteroids) or SCC risk (aHR, 0.94; 95% CI, 0.82-1.08, TCI vs topical corticosteroids). Changing the comparator group to unexposed individuals yielded similar findings (aHR, 1.04; 95% CI, 0.91-1.19, TCI vs unexposed for basal cell carcinoma). There were no associations between TCI dose, frequency, and duration of use and BCC, SCC, or overall KC risk. <h3>Conclusions and Relevance</h3> The results of this postmarketing surveillance study of adult health plan members with AD revealed no apparent association between TCI exposure and overall KC, BCC, or SCC risk. Secondary analyses examining dose, frequency, and duration of TCI exposure revealed no associations. These findings suggest that use of TCIs may be safe with respect to KC risk among adults with AD." @default.
• W3048572815 created "2020-08-18" @default.
• W3048572815 creator A5012783568 @default.
• W3048572815 creator A5028781363 @default.
• W3048572815 creator A5052785465 @default.
• W3048572815 creator A5081343066 @default.
• W3048572815 creator A5084741965 @default.
• W3048572815 date "2020-10-01" @default.
• W3048572815 modified "2023-10-16" @default.
• W3048572815 title "Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis" @default.
• W3048572815 cites W137161715 @default.
• W3048572815 cites W1557897376 @default.
• W3048572815 cites W1841486778 @default.
• W3048572815 cites W1984460862 @default.
• W3048572815 cites W1984482596 @default.
• W3048572815 cites W2025025945 @default.
• W3048572815 cites W2028507366 @default.
• W3048572815 cites W2040600853 @default.
• W3048572815 cites W2054075920 @default.
• W3048572815 cites W2062702626 @default.
• W3048572815 cites W2095901051 @default.
• W3048572815 cites W2109342479 @default.
• W3048572815 cites W2120693753 @default.
• W3048572815 cites W2149157800 @default.
• W3048572815 cites W2164304488 @default.
• W3048572815 cites W2269168103 @default.
• W3048572815 cites W2314617934 @default.
• W3048572815 cites W2319713565 @default.
• W3048572815 cites W2793752870 @default.
• W3048572815 cites W4230355606 @default.
• W3048572815 cites W2017743303 @default.
• W3048572815 doi "https://doi.org/10.1001/jamadermatol.2020.2240" @default.
• W3048572815 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7557510" @default.
• W3048572815 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32785626" @default.
• W3048572815 hasPublicationYear "2020" @default.
• W3048572815 type Work @default.
• W3048572815 sameAs 3048572815 @default.
• W3048572815 citedByCount "30" @default.
• W3048572815 countsByYear W30485728152021 @default.
• W3048572815 countsByYear W30485728152022 @default.
• W3048572815 countsByYear W30485728152023 @default.
• W3048572815 crossrefType "journal-article" @default.
• W3048572815 hasAuthorship W3048572815A5012783568 @default.
• W3048572815 hasAuthorship W3048572815A5028781363 @default.
• W3048572815 hasAuthorship W3048572815A5052785465 @default.
• W3048572815 hasAuthorship W3048572815A5081343066 @default.
• W3048572815 hasAuthorship W3048572815A5084741965 @default.
• W3048572815 hasBestOaLocation W30485728151 @default.
• W3048572815 hasConcept C121608353 @default.
• W3048572815 hasConcept C126322002 @default.
• W3048572815 hasConcept C128057223 @default.
• W3048572815 hasConcept C16005928 @default.
• W3048572815 hasConcept C167135981 @default.
• W3048572815 hasConcept C201903717 @default.
• W3048572815 hasConcept C2776028589 @default.
• W3048572815 hasConcept C2777789703 @default.
• W3048572815 hasConcept C2778329239 @default.
• W3048572815 hasConcept C2778804307 @default.
• W3048572815 hasConcept C2911091166 @default.
• W3048572815 hasConcept C3019992690 @default.
• W3048572815 hasConcept C71924100 @default.
• W3048572815 hasConcept C72563966 @default.
• W3048572815 hasConceptScore W3048572815C121608353 @default.
• W3048572815 hasConceptScore W3048572815C126322002 @default.
• W3048572815 hasConceptScore W3048572815C128057223 @default.
• W3048572815 hasConceptScore W3048572815C16005928 @default.
• W3048572815 hasConceptScore W3048572815C167135981 @default.
• W3048572815 hasConceptScore W3048572815C201903717 @default.
• W3048572815 hasConceptScore W3048572815C2776028589 @default.
• W3048572815 hasConceptScore W3048572815C2777789703 @default.
• W3048572815 hasConceptScore W3048572815C2778329239 @default.
• W3048572815 hasConceptScore W3048572815C2778804307 @default.
• W3048572815 hasConceptScore W3048572815C2911091166 @default.
• W3048572815 hasConceptScore W3048572815C3019992690 @default.
• W3048572815 hasConceptScore W3048572815C71924100 @default.
• W3048572815 hasConceptScore W3048572815C72563966 @default.
• W3048572815 hasIssue "10" @default.
• W3048572815 hasLocation W30485728151 @default.
• W3048572815 hasLocation W30485728152 @default.
• W3048572815 hasOpenAccess W3048572815 @default.
• W3048572815 hasPrimaryLocation W30485728151 @default.
• W3048572815 hasRelatedWork W1511797216 @default.
• W3048572815 hasRelatedWork W156382480 @default.
• W3048572815 hasRelatedWork W1965553868 @default.
• W3048572815 hasRelatedWork W2078314648 @default.
• W3048572815 hasRelatedWork W2112984836 @default.
• W3048572815 hasRelatedWork W2240855959 @default.
• W3048572815 hasRelatedWork W2336509786 @default.
• W3048572815 hasRelatedWork W2432013716 @default.
• W3048572815 hasRelatedWork W2437395753 @default.
• W3048572815 hasRelatedWork W3152324469 @default.
• W3048572815 hasVolume "156" @default.
• W3048572815 isParatext "false" @default.
• W3048572815 isRetracted "false" @default.
• W3048572815 magId "3048572815" @default.
• W3048572815 workType "article" @default.